HABIT Healthy Action to Benefit Independence and Thinking® Registry

Overview

About this study

The purpose of this study is to create this data repository as a mechanism to create a HABIT Registry that houses all retrospective and prospective HABIT-related data in a central database.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

This study will include both a prospective component looking forward, and a retrospective component looking backward.
Participants in the established clinical HABIT program will be invited to participate in this study, including patients diagnosed with Mild Cognitive Impairment and a partner. The partners are often spouses, but could be adult children, other family members, or friends.
In addition, this study includes a retrospective arm, using information already collected under related IRB-approved studies.

Exclusion Criteria:

Any inclusion criteria that cannot be met.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Anne Shandera-Ochsner, Ph.D., L.P.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Miranda Morris B.S., M.S. Morris.Miranda@mayo.edu
La Crosse, Wis. Mayo Clinic principal investigator Anne Shandera-Ochsner, Ph.D., L.P.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Miranda Morris B.S., M.S. Morris.Miranda@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Melanie Chandler, Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Miranda Morris B.S., M.S. Morris.Miranda@mayo.edu
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Dona Locke, Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Natalia Klopotowski (480) 301-4819 Klopotowski.Natalia@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Anne Shandera-Ochsner, Ph.D., L.P.

Closed-enrolling by invitation

Contact information:

Miranda Morris B.S., M.S.

Morris.Miranda@mayo.edu

La Crosse, Wis.

Mayo Clinic principal investigator

Anne Shandera-Ochsner, Ph.D., L.P.

Closed-enrolling by invitation

Contact information:

Miranda Morris B.S., M.S.

Morris.Miranda@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Melanie Chandler, Ph.D.

Closed-enrolling by invitation

Contact information:

Miranda Morris B.S., M.S.

Morris.Miranda@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Dona Locke, Ph.D.

Closed-enrolling by invitation

Contact information:

Natalia Klopotowski

(480) 301-4819

Klopotowski.Natalia@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials